Controlling Shareholder - NEXTEYE
NEXTEYE (137940. KR), founded in 1998 and listed in 2011, is mainly engaged in semiconductor visual inspection, health care products and cosmetics, and financial investment. As of December 31, 2022, NEXTEYE has 38 holding and participating companies worldwide. With the process of globalization, NEXTEYE's business has achieved explosive development and received high attention from the capital market. The highest daily turnover in 2021 will exceed 250 million dollars.
Main Business
The Global Eyesight, high-tech automatic image processing technology replace human eyes.
Perfect International Health Eco-system
The world's largest beauty channel owner - NEXTEYE
Covering sales channels in China, South Korea, Southeast Asia, Japan and the United States With 40000 terminal retail stores and 200 million selected members
Investment Holding Company
Korea's top five cosmetics
production and R&D institutions,
founder of BB cream.
The most authoritative nail company
in Korea, with a market share as high
as 70%, Leading the fashion trend of
Korean nail art.
A Korean hyaluronic acid
manufacturer, the only institution
that has been approved for the
second generation of hyaluronic acid
injections.
Financial Investment
NEXTEYE has successively invested or controlled 7 listed companies, invested or managed more than 10 funds, with a total fund size of more than US $1 billion.
The "CITIC Meishang Health Industry Fund", established in cooperation with CITIC Trust, has a fund scale of 6 billion yuan.
Classic Cases
NEXTEYE spin-off holding subsidiary INNOMETRY Co., Ltd (302430. KR) went public.
In 2016, INNOMETRY Co., Ltd (302430. KR) It is the world's first X-Ray secondary battery testing equipment company. It only took three years to complete the business from scratch, and IPO listing. The company's valuation increased from 2 million yuan to 2.4 billion yuan, up to 1200 times the commercial miracle.
There were 902 participating institutions at the issue price (original shares) before the listing of INNOMETRY Co., Ltd, with a subscription ratio of 765:1.
When NEXTEYE partially exits in 2020, it will obtain 440 times of investment return.
